Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Bojin Biotechnology

Request full access

Specializing in the development of tumor immunotherapy drugs

ChinaFounded 2013

About Suzhou Bojin Biotechnology

Guangzhou Boji Medical and Biotechnology Co., Ltd., also known as Boji Biomedicals (stock code: 300404), is a high-tech contract research organization (CRO) and contract development and manufacturing organization (CDMO). Founded in 2002 and listed on the Shenzhen GEM in 2015, the company provides comprehensive, one-stop services for domestic and international pharmaceutical enterprises.

The company's services cover all stages of new drug research and development. This includes project approval, activity screening, pharmaceutical research on active pharmaceutical ingredients (APIs) and preparations, and drug evaluation for pharmacodynamics and toxicology. Boji also handles clinical research, registration services (including Sino-American), and the commercialization of technological achievements for drugs, medical devices, and health products.

Headquartered in Guangzhou, Boji has established a significant presence with 9 wholly-owned subsidiaries and over 10 holding companies. Its workforce consists of nearly 800 biomedical R&D professionals and legislative experts. The company has demonstrated international service capabilities, undertaking multi-center clinical trials for multinational pharmaceutical firms. Dr. Wang Tingchun, a Medical Doctor from Jinan University, is a key figure with over 20 years of clinical and CRO management experience, leading numerous major national and provincial science and technology projects.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
13.0/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Oct 2023 $14M $55M Changda Investment · Gedian Construction Investment ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Suzhou Bojin Biotechnology website traffic

Latest recorded traffic for Suzhou Bojin Biotechnology is 640 monthly website visits, up 814.3% over the last three months.

Latest monthly visits640 3-month web change+814.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Suzhou Bojin Biotechnology in its local ecosystem

Live from Dealroom

The Suzhou Bojin Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Changda Investment
  • Gedian Construction Investment
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Bojin Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Bojin Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.